Gordon M Ringold
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$6.0MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $6.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 5, 2025 | NIH | SBIR Phase II Phase 1b/2a Trial of QBS-72S for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Patients with Unmethylated MGMT Promoters | $1.3M | QUADRIGA BIOSCIENCES, INC |
| May 9, 2024 | NIH | SBIR Phase II QBS10072S for the Treatment of Brain Metastatic Triple-Negative Breast Cancer | $702K | QUADRIGA BIOSCIENCES, INC |
| Sep 1, 2023 | NIH | SBIR Phase II Phase 1b/2a Trial of QBS-72S for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Patients with Unmethylated MGMT Promoters | $1.3M | QUADRIGA BIOSCIENCES, INC |
| Jul 20, 2023 | NIH | SBIR Phase II QBS10072S for the Treatment of Brain Metastatic Triple-Negative Breast Cancer | $286K | QUADRIGA BIOSCIENCES, INC |
| Aug 31, 2021 | NIH | SBIR Phase II Phase 1b/2a Trial of QBS-72S for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Patients with Unmethylated MGMT Promoters | $1.4M | QUADRIGA BIOSCIENCES, INC |
| Aug 31, 2021 | NIH | SBIR Phase II QBS10072S for the Treatment of Brain Metastatic Triple-Negative Breast Cancer | $1.1M | QUADRIGA BIOSCIENCES, INC |
Peer ranks
Federal funding#186
Awards as PI#315
Patents#273
Companies
- QUADRIGA BIOSCIENCES, INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.